BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Sang-A Kim, Junshik Hong, Woo Chan Park, Dong-Yeop Shin, Youngil Koh, Inho Kim, Dong Soon Lee, Sung-Soo Yoon, Marina Konopleva. Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotypePLOS ONE 2018; 13(12): e0209800 doi: 10.1371/journal.pone.0209800
2
Anne Calleja, Seongseok Yun, Chimène Moreilhon, Jean Michel Karsenti, Lauris Gastaud, Lionel Mannone, Rami Komrokji, Najla Ali, Bérangère Dadone‐montaudie, Guillaume Robert, Patrick Auberger, Sophie Raynaud, David A. Sallman, Thomas Cluzeau. Clonal selection in therapy‐related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatmentEuropean Journal of Haematology 2020; 104(5): 488 doi: 10.1111/ejh.13390
3
Tomáš Szotkowski, Martin Čerňan, Jaromír Hubáček, Milena Holzerová, Tomáš Papajík. Anticancer therapy - related acute myeloid leukemiasOnkologie 2017; 11(3): 115 doi: 10.36290/xon.2017.023
4
Naomi Atkin, Heather Raimer, Yuh-Hwa Wang. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA FragilityGenes 2019; 10(10): 791 doi: 10.3390/genes10100791
5
Sergio Pina-Oviedo, Haitham A. Khogeer, Guilin Tang, Roberto N. Miranda. Oncological Surgical Pathology2020; : 1729 doi: 10.1007/978-3-319-96681-6_17
6
Uma Borate, Brianna A. Norris, Abby Statler, Rongwei Fu, Taylor Bucy, Mikkael A. Sekeres. Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 yearsBlood Advances 2019; 3(18): 2738 doi: 10.1182/bloodadvances.2019000293